Bust #6: The Jellyfish Memory Ad, Slowed Down

🎬 Bust #6 · The Commercial As You See It

A Glowing Jellyfish, A Rising Chart, And A Sharper You

Today's bust is one of the most familiar supplement commercials ever made: the long-running TV ads for Prevagen®, a dietary supplement from Quincy Bioscience. The feeling is calm and hopeful. Your brain is an amazing thing, the ads said — and here is a little capsule, built around a protein originally discovered in a glowing jellyfish, that was presented as the brain's new best friend.

The promises, as viewers heard them for years, were big and specific: it improves memory, it is clinically shown to work, it works within 90 days, it reduces memory problems associated with aging, and it brings a sharper mind and clearer thinking. The Federal Trade Commission (FTC) noted that the TV spots even featured charts depicting rapid and dramatic improvement in memory — a bar chart climbing like a staircase to a better brain.

And down at the bottom, in the usual tiny type with its little asterisk, sat the quietest sentence in the whole commercial: the supplement disclaimer. Today we do what we always do — we slow the chart, the claims, and that tiny sentence waaay down, and we read what the regulators, the courts, and the maker itself actually said. To be fair from the start: the disclaimer WAS in the ads. The joke, as always, is the size and speed — not a secret vault.

🔍 The Fine Print, Slowed Waaay Down

What The Big Words And The Tiny Words Each Mean

• “Clinically shown to improve memory.” In January 2017, the FTC and the New York Attorney General charged the marketers with making false and unsubstantiated claims that the product improves memory, provides cognitive benefits, and is “clinically shown” to work. Their complaint alleged that the study the marketers relied on failed to show that Prevagen works better than a placebo on any measure of cognitive function. In plain English: a study existing, and a study succeeding, are two different sentences — and the ad only read you the first one.
• “Improves memory within 90 days.” That 90-day version was one of the specific claims challenged in the case, along with “clinically shown to improve memory within 90 days” and “reduces memory problems associated with aging.” A deadline in an ad sounds like a promise with a calendar attached. Regulators treated it as a claim that needed solid proof behind it — proof they said was not there.
• “These statements have not been evaluated by the Food and Drug Administration…” This is the famous tiny print, and the FDA explains it on its own website: that disclaimer is required by law when a supplement makes a “structure/function” claim (a claim about how an ingredient affects the body's normal structure or function). The FDA also states plainly that those claims are not approved by the FDA and do not require FDA evaluation before they are used, and that only a drug can legally claim to diagnose, treat, cure, or prevent a disease. Translation: “not evaluated” does not mean “secretly approved.” It means exactly what it says.
• “A supplement made for your brain.*” That asterisked line is how the maker's own website describes the product today. Its FAQ says Prevagen is not a drug but a dietary supplement, sold over the counter with no prescription, formulated with 10 to 40 mg of apoaequorin depending on strength, plus 50 mcg of vitamin D — and that apoaequorin, discovered in jellyfish, is now produced in a controlled scientific process. A supplement, by law, lives in a completely different approval world from a prescription drug.
• The price the feeling never mentioned. The FTC's 2017 complaint said consumers were enticed to spend anywhere from $24 to $68 for bottles of 30 pills at that time. The maker's website today lists 30 capsules of Regular Strength at $39.95 per month and Extra Strength at $59.95 per month. Either way, this was never a one-time purchase in the story — it is a monthly, ongoing one, and the commercials sold the glow, not the subscription.

None of this is us calling anyone names. It is the documented record — a regulator's charges, a court case, and the maker's own current wording — read at normal speed.

🧠 What The Song Doesn't Spell Out

The Court Case, Both Sides, At Walking Pace

1. What the court eventually ordered. On December 10, 2024, the FTC announced its win in the lawsuit, stating that the U.S. District Court for the Southern District of New York had ordered the makers to cease making the claims challenged in the lawsuit. The FTC's Bureau of Consumer Protection director put the lesson in one line: health claims need to be backed up by reliable scientific evidence.

2. What the maker says — because fairness is the whole show here. Quincy Bioscience answers the ruling on its own FAQ page. It says the jury found the principal claims for Prevagen not materially misleading, that the judge found “no intent to harm” and rejected the New York Attorney General's efforts to obtain penalties and disgorgement, and that the order required changes to its advertising going forward — changes the company says it has completed. The company also says it strongly believes the requirement rests on a misreading of the law and the science, and that it is appealing the decision. Both accounts are linked below so you can read each side in its own words.

3. Why the wording mattered so much. The FTC's complaint said product sales had topped $165 million. When a claim is repeated on national television for years, “clinically shown” stops sounding like marketing and starts sounding like a medical fact. That is exactly why regulators require the proof to match the size of the promise — and why the little asterisk sentence deserves to be read just as loudly as the chart.

4. The quiet change you can see yourself. Compare the old ads with the maker's website today: the memory-improvement promises are gone, replaced by the careful line “a supplement made for your brain.*” Same bottle, same jellyfish protein — noticeably smaller words. That difference is the story of this bust.

⚖️ The Busters Verdict

Verdict: The Chart Climbed Faster Than The Evidence

This commercial did not hide its disclaimer in a vault — it printed it, tiny and asterisked, under some of the boldest memory claims on television. Slowed down, the record is genuinely interesting: regulators charged that the headline study did not beat a placebo, a court ordered the challenged claims stopped, and the maker — pointing to jury findings in its favor on material misleadingness, a finding of no intent to harm, and its pending appeal — has already rewritten its marketing into much smaller words. Reasonable people can read both sides. Nobody should have to read either side at auctioneer speed in six-point type.

So here is your Commercial Busters homework — the questions worth taking to a doctor or pharmacist, because they are the professionals and we are not:

• “Is a dietary supplement like this appropriate for me at all, given my health and medicines?”
• “What does ‘not evaluated by the FDA’ mean for a claim I saw in an ad?”
• “If I am worried about my memory, what should we actually check first?”
• “What would this cost me per month, ongoing, and is there a better use of that money for my brain health?”

Sources you can check yourself: FTC and New York Attorney General press release, January 9, 2017, “FTC, New York State Charge the Marketers of Prevagen With Making Deceptive Memory, Cognitive Improvement Claims”: ftc.gov — 2017 charges. FTC case page for Quincy Bioscience Holding Company (matter 152 3206), including the December 10, 2024 “Statement on FTC's Win in Lawsuit Against the Makers of Dietary Supplement Prevagen”: ftc.gov — case page. U.S. Food and Drug Administration, “Questions and Answers on Dietary Supplements” (why the disclaimer is required by law, and that structure/function claims are not approved by FDA): fda.gov — supplement Q&A. The maker's own words — current description, ingredients, prices, and its account of the December 2024 ruling and appeal: prevagen.com — FAQ.

Final reminder: This post is for educational and entertainment purposes only. It is not medical, financial, legal, insurance, or any other professional advice, and it should not be used to make any kind of decision. Talk to a qualified professional about your own situation. Please do not contact us about the products, drugs, policies, or services covered here — we do not provide advice on any of them.